Intervention

89Zr-trastuzumab

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

HER2-PET Imaging in HER2-low Breast CancersNCT06732336 · 2024-12-01

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?NCT02286843 · 2014-11-06

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1NCT01565200 · 2012-05-01

Common conditions

Breast Cancer Metastases1 Breast Cancer Metastatic1 HER-2 Positive Breast Cancer1 HER2 Positive Breast1

Leading sponsors

Centre de recherche du Centre hospitalier universitaire de Sherbrooke1 Jules Bordet Institute1 Memorial Sloan Kettering Cancer Center1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

PHASE22

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.